SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 459 filers reported holding SEAGEN INC in Q2 2021. The put-call ratio across all filers is 0.46 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,435,208 | +49.9% | 20,906 | +36.0% | 0.16% | +52.8% |
| Q2 2023 | $2,958,110 | -0.2% | 15,370 | +5.0% | 0.11% | -13.8% |
| Q1 2023 | $2,964,971 | +45.1% | 14,644 | -7.9% | 0.12% | -42.5% |
| Q4 2022 | $2,043,695 | -6.1% | 15,903 | 0.0% | 0.21% | +107.8% |
| Q3 2022 | $2,176,000 | -22.7% | 15,903 | 0.0% | 0.10% | -18.9% |
| Q2 2022 | $2,814,000 | +22.8% | 15,903 | 0.0% | 0.13% | +49.4% |
| Q1 2022 | $2,291,000 | -2.3% | 15,903 | +4.8% | 0.08% | +2.4% |
| Q4 2021 | $2,345,000 | -5.6% | 15,169 | +3.7% | 0.08% | -14.4% |
| Q3 2021 | $2,485,000 | +7.6% | 14,632 | 0.0% | 0.10% | +11.5% |
| Q2 2021 | $2,310,000 | +13.7% | 14,632 | 0.0% | 0.09% | +22.5% |
| Q1 2021 | $2,032,000 | -7.9% | 14,632 | +16.2% | 0.07% | -28.3% |
| Q4 2020 | $2,206,000 | – | 12,593 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 46,912,266 | $6,419,005,000 | 42.04% |
| Ally Bridge Group (NY) LLC | 92,506 | $12,658,000 | 8.36% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 166,200 | $22,739,000 | 7.29% |
| Eagle Health Investments LP | 174,902 | $23,932,000 | 5.49% |
| Avoro Capital Advisors LLC | 1,865,000 | $255,188,000 | 4.71% |
| Lagoda Investment Management, L.P. | 47,955 | $6,562,000 | 4.67% |
| Nan Fung Group Holdings Ltd | 47,096 | $6,444,000 | 4.11% |
| Ikarian Capital, LLC | 150,000 | $20,525,000 | 4.09% |
| Antara Capital LP | 946,100 | $129,455,000 | 3.42% |
| SECTOR GAMMA AS | 84,730 | $11,594,000 | 2.99% |